Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells

Sandra Cascio, Rita Ferla, Aleco D'Andrea, Aldo Gerbino, Viviana Bazan, Eva Surmacz, Antonio Russo

Research output: Contribution to journalArticle

Abstract

Both leptin and vascular endothelial growth factor (VEGF) are growth and angiogenic cytokines that are upregulated in different types of cancer and have been implicated in neoplastic progression. Here we investigated the molecular mechanism by which leptin and VEGF expression are regulated in colon cancer by epidermal growth factor (EGF). In colon cancer cell line HT-29, EGF induced the binding of signal transducer and activator transcription 3 (STAT3) to STAT3 consensus motifs within the VEGF and leptin promoters and stimulated leptin and VEGF mRNA and protein synthesis. All these EGF effects were significantly blocked when HT-29 cells were treated with an inhibitor of the phosphoinositide 3-kinase (PI3K) pathway, LY294002, or with small interfering RNA (siRNA) targeting STAT3. Thus, our study identified the EGF/PI3K/STAT3 signaling as an essential pathway regulating VEGF and leptin expression in EGF-responsive colon cancer cells. This suggests that STAT3 pathways might constitute attractive pharmaceutical targets in colon cancer patients where anti-EGF receptor drugs are ineffective.

Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalJournal of Cellular Physiology
Volume221
Issue number1
DOIs
Publication statusPublished - Oct 2009

Fingerprint

STAT3 Transcription Factor
1-Phosphatidylinositol 4-Kinase
Phosphatidylinositols
Leptin
Epidermal Growth Factor
Vascular Endothelial Growth Factor A
Colorectal Neoplasms
Phosphotransferases
Colonic Neoplasms
Cells
HT29 Cells
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Epidermal Growth Factor Receptor
Pharmaceutical Preparations
Small Interfering RNA
Cytokines
Cell Line
Messenger RNA
Growth
Neoplasms

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology

Cite this

Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. / Cascio, Sandra; Ferla, Rita; D'Andrea, Aleco; Gerbino, Aldo; Bazan, Viviana; Surmacz, Eva; Russo, Antonio.

In: Journal of Cellular Physiology, Vol. 221, No. 1, 10.2009, p. 189-194.

Research output: Contribution to journalArticle

Cascio, Sandra ; Ferla, Rita ; D'Andrea, Aleco ; Gerbino, Aldo ; Bazan, Viviana ; Surmacz, Eva ; Russo, Antonio. / Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells. In: Journal of Cellular Physiology. 2009 ; Vol. 221, No. 1. pp. 189-194.
@article{5b04fd897ca44eb782008cbc7a87c9d5,
title = "Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells",
abstract = "Both leptin and vascular endothelial growth factor (VEGF) are growth and angiogenic cytokines that are upregulated in different types of cancer and have been implicated in neoplastic progression. Here we investigated the molecular mechanism by which leptin and VEGF expression are regulated in colon cancer by epidermal growth factor (EGF). In colon cancer cell line HT-29, EGF induced the binding of signal transducer and activator transcription 3 (STAT3) to STAT3 consensus motifs within the VEGF and leptin promoters and stimulated leptin and VEGF mRNA and protein synthesis. All these EGF effects were significantly blocked when HT-29 cells were treated with an inhibitor of the phosphoinositide 3-kinase (PI3K) pathway, LY294002, or with small interfering RNA (siRNA) targeting STAT3. Thus, our study identified the EGF/PI3K/STAT3 signaling as an essential pathway regulating VEGF and leptin expression in EGF-responsive colon cancer cells. This suggests that STAT3 pathways might constitute attractive pharmaceutical targets in colon cancer patients where anti-EGF receptor drugs are ineffective.",
author = "Sandra Cascio and Rita Ferla and Aleco D'Andrea and Aldo Gerbino and Viviana Bazan and Eva Surmacz and Antonio Russo",
year = "2009",
month = "10",
doi = "10.1002/jcp.21843",
language = "English",
volume = "221",
pages = "189--194",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/PI3K/STAT3 pathway in colorectal cancer cells

AU - Cascio, Sandra

AU - Ferla, Rita

AU - D'Andrea, Aleco

AU - Gerbino, Aldo

AU - Bazan, Viviana

AU - Surmacz, Eva

AU - Russo, Antonio

PY - 2009/10

Y1 - 2009/10

N2 - Both leptin and vascular endothelial growth factor (VEGF) are growth and angiogenic cytokines that are upregulated in different types of cancer and have been implicated in neoplastic progression. Here we investigated the molecular mechanism by which leptin and VEGF expression are regulated in colon cancer by epidermal growth factor (EGF). In colon cancer cell line HT-29, EGF induced the binding of signal transducer and activator transcription 3 (STAT3) to STAT3 consensus motifs within the VEGF and leptin promoters and stimulated leptin and VEGF mRNA and protein synthesis. All these EGF effects were significantly blocked when HT-29 cells were treated with an inhibitor of the phosphoinositide 3-kinase (PI3K) pathway, LY294002, or with small interfering RNA (siRNA) targeting STAT3. Thus, our study identified the EGF/PI3K/STAT3 signaling as an essential pathway regulating VEGF and leptin expression in EGF-responsive colon cancer cells. This suggests that STAT3 pathways might constitute attractive pharmaceutical targets in colon cancer patients where anti-EGF receptor drugs are ineffective.

AB - Both leptin and vascular endothelial growth factor (VEGF) are growth and angiogenic cytokines that are upregulated in different types of cancer and have been implicated in neoplastic progression. Here we investigated the molecular mechanism by which leptin and VEGF expression are regulated in colon cancer by epidermal growth factor (EGF). In colon cancer cell line HT-29, EGF induced the binding of signal transducer and activator transcription 3 (STAT3) to STAT3 consensus motifs within the VEGF and leptin promoters and stimulated leptin and VEGF mRNA and protein synthesis. All these EGF effects were significantly blocked when HT-29 cells were treated with an inhibitor of the phosphoinositide 3-kinase (PI3K) pathway, LY294002, or with small interfering RNA (siRNA) targeting STAT3. Thus, our study identified the EGF/PI3K/STAT3 signaling as an essential pathway regulating VEGF and leptin expression in EGF-responsive colon cancer cells. This suggests that STAT3 pathways might constitute attractive pharmaceutical targets in colon cancer patients where anti-EGF receptor drugs are ineffective.

UR - http://www.scopus.com/inward/record.url?scp=69249227496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249227496&partnerID=8YFLogxK

U2 - 10.1002/jcp.21843

DO - 10.1002/jcp.21843

M3 - Article

C2 - 19492417

AN - SCOPUS:69249227496

VL - 221

SP - 189

EP - 194

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 1

ER -